EDIT vs UBER
Editas Medicine Inc (EDIT) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
EDIT currently screens at market cap $375.2M. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the EDIT and UBER stock pages for the full models.
Not investment advice.